Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 286 blog entries.

MHRA Drug Safety Update: IXCHIQ Chikungunya vaccine – updates to restrictions of use following safety review

Following the completion of a safety review and the recommendations of the Commission on Human Medicines (CHM), the IXCHIQ Chikungunya vaccine is no longer indicated for adults over the age of 60 years, and is contraindicated in all individuals with hypertension, cardiovascular disease, diabetes mellitus, and/or chronic kidney disease. This action follows very rare fatal [...]

The post MHRA Drug Safety Update: IXCHIQ Chikungunya vaccine – updates to restrictions of use following safety review appeared first on Community Pharmacy England.

By |February 11th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: IXCHIQ Chikungunya vaccine – updates to restrictions of use following safety review

Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the January 2026 concessionary price for Rosuvastatin 10mg tablets and Trimethoprim 100mg tablets: Drug Pack size Price concession Rosuvastatin 10mg tablets 28 £4.48 (previously £2.70) Trimethoprim 100mg tablets 28 £4.08 (previously £3.77) [...]

The post Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026 appeared first on Community Pharmacy England.

By |February 6th, 2026|Lexpos News|Comments Off on Improved price concession for Rosuvastatin 10mg tablets & Trimethoprim 100mg tablets for January 2026

MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatment of type 2 diabetes, weight management and cardiovascular risk reduction. Patients reporting a sudden loss of vision (including partial loss) while [...]

The post MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) appeared first on Community Pharmacy England.

By |February 5th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Semaglutide (Wegovy®, Ozempic® and Rybelsus®): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)

MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) Drug alert number: EL(26)A/05 Date issued: 2 February 2026 Accord Healthcare limited is recalling a single batch due to an out of specification test result. DMRC reference number: DMRC-38091819 Company name: Accord Healthcare Ltd Medicine Details Carmustine [...]

The post MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

By |February 2nd, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Carmustine 100mg powder and solvent for concentrate for solution for infusion (Accord Healthcare Ltd)

11 products added to the Discount Not Deducted (DND) list from February 2026

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 11 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2026. This takes the total [...]

The post 11 products added to the Discount Not Deducted (DND) list from February 2026 appeared first on Community Pharmacy England.

By |February 1st, 2026|Lexpos News|Comments Off on 11 products added to the Discount Not Deducted (DND) list from February 2026